HALO in “The Patent Cliff Sparks a Biotech Land Grab”
Halozyme Therapeutics, Inc.
Halozyme's drug-delivery technology and royalty model let it monetize partners' efforts to extend franchises and improve biologic product profiles.
HALO impact map — “The Patent Cliff Sparks a Biotech Land Grab”
How this story travels from the headline to HALO’s own business — positive, negative or mixed, direct or indirect, the mechanism, and how strong the exposure is.
Loading HALO impact map…
Price history, marked with story events
Aug 14, 2023 – Aug 12, 2024 · 251 sessions
Prices updated during market hours · refreshed about every 30 minutes while the market is open · delayed data, not for trading decisions
Numbered markers tie price moves to earnings, trial or study results, management comments and analyst or demand data. Loading events…
Full story
The Patent Cliff Sparks a Biotech Land Grab
Large drugmakers facing revenue holes must buy scarce pipelines, turning clinical validation into strategic currency.
BULL side — Halozyme's drug-delivery technology and royalty model let it monetize partners' efforts to extend franchises and improve biologic product profiles.
Read the full The Patent Cliff Sparks a Biotech Land Grab story